ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 209 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $11,993,000 | -37.9% | 352,825 | -25.4% | 0.03% | -38.6% |
| Q2 2021 | $19,320,000 | -6.8% | 472,825 | -8.2% | 0.04% | -13.7% |
| Q1 2021 | $20,740,000 | -32.9% | 515,158 | -1.5% | 0.05% | -32.9% |
| Q4 2020 | $30,918,000 | +22.6% | 522,882 | +0.8% | 0.08% | -1.3% |
| Q3 2020 | $25,216,000 | +1.1% | 518,525 | +0.5% | 0.08% | -14.4% |
| Q2 2020 | $24,951,000 | +74.6% | 515,725 | +0.2% | 0.09% | +28.6% |
| Q1 2020 | $14,292,000 | -38.4% | 514,474 | -33.7% | 0.07% | -21.3% |
| Q4 2019 | $23,218,000 | -12.6% | 776,019 | -9.7% | 0.09% | -18.3% |
| Q3 2019 | $26,558,000 | -16.3% | 859,468 | +30.9% | 0.11% | -14.2% |
| Q2 2019 | $31,723,000 | – | 656,800 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
| Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
| Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
| Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
| Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
| DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
| ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
| Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
| Triatomic Management LP | 102,889 | $560,745 | 0.39% |